Nobiletin reduces LPL-mediated lipid accumulation and pro-inflammatory cytokine secretion through upregulation of miR-590 expression. [electronic resource]
Producer: 20190603Description: 97-101 p. digitalISSN:- 1090-2104
- Atherosclerosis -- drug therapy
- Cardiotonic Agents -- pharmacology
- Cytokines -- metabolism
- Down-Regulation -- drug effects
- Drug Development
- Flavones -- pharmacology
- Humans
- Inflammation Mediators -- metabolism
- Lipid Metabolism -- drug effects
- Lipoprotein Lipase -- antagonists & inhibitors
- Macrophages -- drug effects
- MicroRNAs -- genetics
- THP-1 Cells
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.